PGNY
HealthcareProgyny, Inc.
$26.66
+$0.92 (+3.57%)
Jan 5, 2026
Price History (1Y)
Analysis
Progyny, Inc. is a healthcare company that operates in the Healthcare Plans sector and Industry. The company has a market capitalization of $2.30 billion and generates revenue of $1.27 billion (TTM), employing 675 individuals. The company's financial health is characterized by relatively high profitability margins, with gross margin at 22.9%, operating margin at 6.9%, and profit margin at 4.5%. Progyny also demonstrates strong returns on equity at 11.4% and return on assets at 7.4%. On the balance sheet side, the company has a debt to equity ratio of 5.03 and cash reserves of $345.21 million, while total debt stands at $28.15 million. Progyny's valuation context shows a price-to-earnings (P/E) ratio of 41.66 (TTM), with a forward P/E of 13.61, indicating potential for growth. The company has achieved revenue growth of 9.3% year-over-year and earnings growth of 36.4%, while its beta is 0.94, suggesting lower volatility compared to the market.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Progyny, Inc.
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Visit website →Key Statistics
- Market Cap
- $2.30B
- P/E Ratio
- 41.66
- 52-Week High
- $27.76
- 52-Week Low
- $17.01
- Avg Volume
- 1.65M
- Beta
- 0.94
Company Info
- Industry
- Healthcare Plans
- Exchange
- NMS
- Country
- United States
- Employees
- 675